← Back to Clinical Trials
Recruiting NCT07686783

NCT07686783 Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07686783
Status Recruiting
Phase
Sponsor Benha University
Condition Ovarian Cysts
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-06-30
Primary Completion 2027-06

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Laparoscopic Ovarian Cystectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-06-30 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

We will conduct this study to estimate the effect of laparoscopic cystectomy on ovarian reserve in endometriotic cysts versus non-endometriotic cysts.

Eligibility Criteria

Inclusion Criteria: * Female patients aged 18-45 years * Ovarian cyst measuring 6-15 cm in diameter, confirmed by transvaginal ultrasound or MRI * Cyst is persistent for more than 3 months if asymptomatic, OR any symptomatic cyst regardless of duration of diagnosis * Serum anti-Müllerian hormone (AMH) level ≥ 2 ng/mL, measured within 1 month preoperatively * Willingness to participate and provide written informed consent Exclusion Criteria: * Clinical or ultrasonic suspicion of ovarian malignancy * Ovarian cyst associated with pregnancy * Previous history of ovarian surgery * History of pelvic irradiation or chemotherapy * Known endocrine disorders affecting ovarian function (e.g., PCOS, premature ovarian insufficiency, thyroid dysfunction, hyperprolactinemia) * Current use of hormonal contraceptives or hormonal therapy within 3 months prior to enrollment * Presence of severe systemic disease that contraindicates surgery or general anesthesia * Refusal to participate or inability to provide informed consent

Contact & Investigator

Central Contact

AHMED ALNEZAMY, MD

✉ AHMED.ALNZAMY@fmed.bu.edu.eg

📞 01224849065

Principal Investigator

AHMED ALNEZAMY, MD

PRINCIPAL INVESTIGATOR

Lecturer of Obstetrics and Gynecology, Faculty of Medicine, Benha University

Frequently Asked Questions

Who can join the NCT07686783 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Ovarian Cysts. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07686783 currently recruiting?

Yes, NCT07686783 is actively recruiting participants. Contact the research team at AHMED.ALNZAMY@fmed.bu.edu.eg for enrollment information.

Where is the NCT07686783 trial being conducted?

This trial is being conducted at Banhā, Egypt.

Who is sponsoring the NCT07686783 clinical trial?

NCT07686783 is sponsored by Benha University. The principal investigator is AHMED ALNEZAMY, MD at Lecturer of Obstetrics and Gynecology, Faculty of Medicine, Benha University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology